Ann: IHL-675A outperforms existing treatment for arthritis, page-89

First 89 Last

Share
Profile

Follow
ASXleo

3,387 Posts.

294

17/03/21

18:37

Post #: 51843740
Share

Originally posted by Mattstamb: ↑

Perhaps the BOD has cried wolf too many times with their Friday trading halts. So predictable, that this one was even predicted by some on this forum! But this one, just like the last few, couldn't even attract day traders trying to pump and dump the release! Couldn't even hold onto yesterdays close! Another fluffy announcement, with yet another claim in its title which is not supported in anyway in the announcement text.

Looks like the market thinks they should be concentrating on achieving at least one thing, rather than just promising lots of things. Lots of red flags here until they follow through on at least one project.

Some heavy ramping by the same names on these forums. I wonder if its just the same person with different handles? Anyone who questions what is happening gets shouted down.

How can an Oil sales company have a market cap of over 200 million? Real Bio tech companies have this MC, or even less, when conducting Phase 2 trials. Phase 2 trials, by the way, are when humans are involved. Can anyone find any pre-clinical phase company with a similar MC?

But at least we know the rats are doing ok.

Also a very good idea to wait until tomorrow to top up Chaya, as the "numbnuts" will continue to sell. Wait a bit longer and you will save even more money.

Removing this one from the watch list.

Expand

so funny, can you nominate just one of all those you are talking about that generate 1$ ? will IHL generate money + got very advanced potential.

IHL Price at posting: 21.0¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Trump is President Again: What Does This Mean for Crypto?

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IMU

Imugene kicks off Australian trial for blood cancer treatment

HotCopper Highlights: Your most watched and most discussed stocks this week

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?